All news

GT Biopharma registers 13.5M shares for resale

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

GT Biopharma has registered up to 13.5 million common shares for resale, far exceeding its roughly 2 million shares currently outstanding. The filing covers shares held by selling stockholders from conversions, warrants and dividends, and the company receives no proceeds from these resales. The registration signals potential dilution, a key risk for investors alongside clinical progress.

Read original source

GTBP company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.